This cutting-edge volume is the first to address the burgeoning interest in drugs and Africa among scholars, policymakers, and the general public. It brings together an interdisciplinary group of leading academics and practitioners to explore the use, trade, production, and control of mind-altering substances on the continent

Nigerian drug lords in UK prisons, khat-chewing Somali pirates hijacking Western ships, crystal meth-smoking gangs controlling South Africa's streets, and narco-traffickers corrupting the state in Guinea-Bissau: these are some of the vivid images surrounding drugs in Africa which have alarmed policymakers, academics and the general public in recent years. In this revealing and original book, the authors weave these aspects into a provocative argument about Africa's role in the global trade and control of drugs. In doing so, they show how foreign-inspired policies have failed to help African drug users but have strengthened the role of corrupt and brutal law enforcement officers, who are tasked with halting the export of heroin and cocaine to European and American consumer markets. A vital book on an overlooked front of the so-called war on drugs.

Drawing on contributions from seven countries in Africa; two countries in Europe; and seven countries in the Americas, this volume examines the relationships between drug use, drug trafficking, drug controls and the black population of a given society. Each chapter examines the nature and pattern of drug use or abuse; the effects of drug use or abuse (illegal or/and legal) on other areas such as health and crime; the nature, pattern, and perpetration of trafficking and sale of illegal or/and legal drugs; and past and current policies and control of illegal and /or legal drugs. It will be essential reading for all students, academics and policy-makers working in the area of drug control.

This book is open access under a CC-BY license. The importance of the pharmaceutical industry in Sub-Saharan Africa, its claim to policy priority, is rooted in the vast unmet health needs of the sub-continent. Making Medicines in Africa is a collective endeavour, by a group of contributors with a strong African and more broadly Southern presence, to find ways to link technological development, investment and industrial growth in pharmaceuticals to improve access to essential good quality medicines, as part of moving towards universal access to competent health care in Africa. The authors aim to shift the emphasis in international debate and initiatives towards sustained Africa-based and African-led initiatives to tackle this huge challenge. Without the technological, industrial, intellectual, organisational and research-related capabilities associated with competent pharmaceutical production, and without policies that pull the industrial sectors towards serving local health needs, the African sub-continent cannot generate the resources to tackle its populations' needs and demands. Research for this book has been selected as one of the 20 best examples of the impact of UK research on development. See http://www.ukcds.org.uk/the-global-impact-of-uk-research for further details.

"The authors show that drugs possessed characteristics that made them a particularly effective means for propagating trade or increasing the extent and intensity of labor. In the early stages of European expansion, drugs were introduced to draw people, quite literally, into relations of dependency with European trade partners. Over time, the drugs used to intensify the amount and duration of labor shifted from alcohol, opium, and marijuana - which were used to overcome the drudgery and discomfort of physical labor - to caffeine-based stimulants, which provided a more alert workforce."--BOOK JACKET.

The 2019 World Drug Report will include an updated overview of recent trends on production, trafficking and consumption of key illicit drugs. The Report contains a global overview of the baseline data and estimates on drug demand and supply and provides the reference point for information on the drug situation worldwide.

Throughout the African American community, individuals and organizations ranging from churches to schools to drug treatment centers are fighting the widespread use of crack cocaine. To put that fight in a larger cultural context, Doin' Drugs explores historical patterns of alcohol and drug use from pre-slavery Africa to present-day urban America. William Henry James and Stephen Lloyd Johnson document the role of alcohol and other drugs in traditional African cultures, among African slaves before the American Civil War, and in contemporary African American society, which has experienced the epidemics of marijuana, heroin, crack cocaine, and gangs since the beginning of this century. The authors zero in on the interplay of addiction and race to uncover the social and psychological factors that underlie addiction. James and Johnson also highlight many culturally informed programs, particularly those sponsored by African American churches, that are successfully breaking the patterns of addiction. The authors hope that the information in this book will be used to train a new generation of counselors, ministers, social workers, nurses, and physicians to be better prepared to face the epidemic of drug addiction in African American communities.

For more than 50 years, low-cost antimalarial drugs silently saved millions of lives and cured billions of debilitating infections. Today, however, these drugs no longer work against the deadliest form of malaria that exists throughout the world. Malaria deaths in sub-Saharan Africaâ€"currently just over one million per yearâ€"are rising because of increased resistance to the old, inexpensive drugs. Although effective new drugs called "artemisinins" are available, they are unaffordable for the majority of the affected population, even at a cost of one dollar per course. Saving Lives, Buying Time: Economics of Malaria Drugs in an Age of Resistance examines the history of malaria treatments, provides an overview of the current drug crisis, and offers recommendations on maximizing access to and effectiveness of antimalarial drugs. The book finds that most people in endemic countries will not have access to currently effective combination treatments, which should include an artemisinin, without financing from the global community. Without funding for effective treatment, malaria mortality could double over the next 10 to 20 years and transmission will intensify.

After arriving from South Asia approximately a thousand years ago, cannabis quickly spread throughout the African continent. European accounts of cannabis in Africa—often fictionalized and reliant upon racial stereotypes—shaped widespread myths about the plant and were used to depict the continent as a cultural backwater and Africans as predisposed to drug use. These myths continue to influence contemporary thinking about cannabis. In The African Roots of Marijuana, Chris S. Duvall corrects common misconceptions while providing an authoritative history of cannabis as it flowed into, throughout, and out of Africa. Duvall shows how preexisting smoking cultures in Africa transformed the plant into a fast-acting and easily dosed drug and how it later became linked with global capitalism and the slave trade. People often used cannabis to cope with oppressive working conditions under colonialism, as a recreational drug, and in religious and political movements. This expansive look at Africa's importance to the development of human knowledge about marijuana will challenge everything readers thought they knew about one of the world's most ubiquitous plants.

Synthesizing Hope opens up the material and social world of pharmaceuticals by focusing on an unexpected place: iThemba Pharmaceuticals. Founded in 2009 with a name taken from the Zulu word for hope, the small South African startup with an elite international scientific board was tasked with drug discovery for tuberculosis, HIV, and malaria. Anne Pollock uses this company as an entry point for exploring how the location of scientific knowledge production matters, not only for the raw materials, manufacture, licensing, and distribution of pharmaceuticals but also for the making of basic scientific knowledge. Consideration of this case exposes the limitations of global health frameworks that implicitly posit rich countries as the only sites of knowledge production. Analysis of iThemba identifies the problems inherent in global north/south divides at the same time as it highlights what is at stake in who makes knowledge and where. It also provides a concrete example for consideration of the contexts and practices of postcolonial science, its constraints, and its promise. Synthesizing Hope explores the many legacies that create conditions of possibility for South African drug discovery, especially the specific form of settler colonialism characterized by apartheid and resource extraction. Paying attention to the infrastructures and laboratory processes of drug discovery underscores the materiality of pharmaceuticals from the perspective of their makers, and tracing the intellectual and material infrastructures of South African drug discovery contributes new insights about larger social, political, and economic orders.